Zobrazeno 1 - 10
of 32
pro vyhledávání: '"S, Tsoussis"'
Autor:
S, Tsoussis, M, Papadogiorgaki, E, Markodimitraki, G, Delibaltadakis, A, Strevinas, M, Psyllakis, K, Tabakaki, I, Drossitis, A, Kabourakis, E, Papadimitraki, S, Krypotos, K, Daskalakis, G, Fragiadaki, E, Zoumadaki, S, Apostolakis
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 18(2)
To analyze the attitude of Greek health professionals towards truth disclosure and factors that may influence it.Through a self-completed questionnaire, we studied the attitudes over the initial disclosure of cancer diagnosis to cancer patients of 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46dd12d25085c4fa31fa1d64b6a50fba
https://pubmed.ncbi.nlm.nih.gov/23818371
https://pubmed.ncbi.nlm.nih.gov/23818371
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 14(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f6b2f98fb50d402787a6175a574684c
https://pubmed.ncbi.nlm.nih.gov/20148471
https://pubmed.ncbi.nlm.nih.gov/20148471
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 14(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da2918de7b8c3711dd2257afc5cc7250
https://pubmed.ncbi.nlm.nih.gov/20148474
https://pubmed.ncbi.nlm.nih.gov/20148474
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 12(3)
Symptoms, palliative applications and terminal phase (TP) duration mainly constitute clinical burden of TP in cancer. The aim of this study was to describe palliative issues and determine factors that might influence the clinical burden during TP.We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90973bbad7bc0074a6040820594d1e99
https://pubmed.ncbi.nlm.nih.gov/17918293
https://pubmed.ncbi.nlm.nih.gov/17918293
Publikováno v:
Clinical Oncology. 18:158-159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aae34ea380f56fed7421a97e8d616b0
https://doi.org/10.1016/j.clon.2005.12.001
https://doi.org/10.1016/j.clon.2005.12.001
Autor:
M. Vassilomanolakis, A. Ferderigou, A. P. Efremidis, N. Baziotis, K. Kandylis, S. Tsoussis, A. Papadimitriou
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 1(6)
Concentrations of the tumour-associated antigens CEA, CA 15-3 and CA 125 were determined in serous effusions (EF) from patients (pts) with breast cancer. As controls, serous effusions from patients with benign and other malignant diseases were used.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c04feea729efa8673393d2bd4448a7
https://pubmed.ncbi.nlm.nih.gov/2083187
https://pubmed.ncbi.nlm.nih.gov/2083187
Autor:
M. Vassilomanolakis, M. Moraki, V. Barbounis, Anna Efremidis, George Koumakis, S. Tsoussis, E. Hajichristou
Publikováno v:
European Journal of Cancer. 29:S54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0767b9f1cc2ec31e6fc279e9d9f6d8fa
https://doi.org/10.1016/0959-8049(93)90889-n
https://doi.org/10.1016/0959-8049(93)90889-n
Publikováno v:
Cancer chemotherapy and pharmacology. 24(6)
Ifosfamide (IFS) is a new alkylating oxazaphosphorine related to cyclophosphamide. Various side effects have been reported; however, cardiotoxicity is not known to occur in humans. We report for first time acute cardiac side effects upon IFS treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1087a8281e606df9734b380a46253505
https://pubmed.ncbi.nlm.nih.gov/2791194
https://pubmed.ncbi.nlm.nih.gov/2791194
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.